Anti-HB-EGF Antibody-Mediated Delivery of siRNA to Atherosclerotic Lesions in Mice-Reference-Cited by-同舟云学术

Anti-HB-EGF Antibody-Mediated Delivery of siRNA to Atherosclerotic Lesions in Mice

Published:2018-11-30 Issue:6 Volume:59 Page:1425-1431
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Tsuchida Shota¹,Matsuzaki Takashi²,Yamato Masaki¹,Okuda Keiji¹,Fu Hai Ying¹,Araki Ryo¹,Sanada Shoji¹,Asanuma Hiroshi³,Asano Yoshihiro¹,Asakura Masanori⁴,Hao Hiroyuki⁵,Takashima Seiji⁶,Kitakaze Masafumi⁷,Sakata Yasushi¹,Mekada Eisuke⁸,Minamino Tetsuo²

Affiliation:

1. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

2. Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University

3. Department of Internal Medicine, Meiji University of Integrative Medicine

4. Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine

5. Department of Pathology, Nihon University School of Medicine

6. Department of Medical Biochemistry, Osaka University Graduate School of Medicine

7. Clinical Research and Development, National Cerebral and Cardiovascular Center Research Institute

8. Department of Cell Biology, Research Institute for Microbial Diseases, Osaka University

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/59/6/59_17-644/_pdf

Reference33 articles.

1. 1. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013; 368: 2004-13.

2. 2. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 18: 245-54.

3. 3. Grundy SM. Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention. Circulation 2008; 117: 569-73.

4. 4. Kivelä AM, Huusko J, Ylä-Herttuala S. Prospect and progress of gene therapy in treating atherosclerosis. Expert Opin Biol Ther 2015; 15: 1699-712.

5. 5. Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. Non-viral vectors for gene-based therapy. Nat Rev Genet 2014; 15: 541-55.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Analyses of the Intracellular and in Vivo Disposition of Fab– Small Interfering RNA Conjugate to Identify Key Issues to Improve Its in Vivo Activity;Drug Metabolism and Disposition;2022-12-02

2. Serum biomarkers associated with SARS-CoV-2 severity;Scientific Reports;2022-09-26

3. Useful applications of growth factors for cardiovascular regenerative medicine;Growth Factors;2020-01-02